These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4286905)

  • 1. [Immunizing action on monkeys of normal and guanidine-dependent Sabin poliovirus].
    Loddo B; Schivo ML; Gessa GL
    Arch Sci Biol (Bologna); 1965; 49(3):206-11. PubMed ID: 4286905
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACQUISITION IN VITRO OF GUANIDINE-DEPENDENCE BY SABIN STRAINS OF POLIOVIRUS 1, 2, AND 3].
    LODDO B; BROTZU G; SPANEDDA A; FERRARI W
    Boll Soc Ital Biol Sper; 1963 Sep; 39():1006-7. PubMed ID: 14090494
    [No Abstract]   [Full Text] [Related]  

  • 3. POLIOVIRUS: GUANIDINE DEPENDENCE AND LOSS OF NEUROVIRULENCE FOR MONKEYS.
    LODDO B; BROTZU G; SPANEDDA A; GESSA GL; FERRARI W
    Science; 1964 Aug; 145(3635):945-6. PubMed ID: 14163823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EVALUATION OF NEURAL LESIONS IN MONKEYS INOCULATED WITH SABIN POLIOVIRUS VACCINE].
    LUSSIER G; PAVILANIS V; DIFRANCO E
    Rev Can Biol; 1964 Sep; 23():323-32. PubMed ID: 14237165
    [No Abstract]   [Full Text] [Related]  

  • 6. A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.
    Vonka V; Janda Z; Simon J; Adam E; Stárek M
    Prog Med Virol; 1967; 9():204-55. PubMed ID: 4293687
    [No Abstract]   [Full Text] [Related]  

  • 7. [PROTECTION OF CERCOPITHECUS AETHIOPS AGAINST VIRULENT POLIOVIRUS BY INOCULATION WITH GUANIDINE-DEPENDENT POLIOVIRUS].
    LODDO B; FERRARI W; SPANEDDA A; BROTZU G
    Boll Soc Ital Biol Sper; 1963 Sep; 39():1003-4. PubMed ID: 14090492
    [No Abstract]   [Full Text] [Related]  

  • 8. [ANTIGENIC BEHAVIOR OF STRAINS OF GUANIDINE-DEPENDENT POLIOVIRUS].
    BROTZU G; FERRARI W
    Rass Med Sarda; 1964; 66():207-13. PubMed ID: 14221417
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.
    Rezapkin GV; Alexander W; Dragunsky E; Parker M; Pomeroy K; Asher DM; Chumakov KM
    Virology; 1998 Jun; 245(2):183-7. PubMed ID: 9636357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Viral synthesis in cells infected simultaneously with guanidine sensitive and guanidine dependent poliovirus].
    Mazzucato P; Tagliamonte A; Molle A; Loddo B
    Riv Ist Sieroter Ital; 1968; 43(2):73-81. PubMed ID: 4301113
    [No Abstract]   [Full Text] [Related]  

  • 11. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
    Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
    Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succession of mutations in the Sabin strain of type 3 poliovirus replicating in the central nervous system of monkeys.
    Lu Z; Asher DM; Levenbook IS; Chumakov KM
    Virology; 1996 Jun; 220(2):285-9. PubMed ID: 8661379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-existence of a guanidine-dependence and of a thiopyrimidine dependence in the same strain of poliovirus.
    Marcialis MA; Atzeni A; Biondi E; Loddo B
    Experientia; 1973 Feb; 29(2):236-7. PubMed ID: 4348195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Protection of the monkey against experimental poliovirus infection by means of preventive inoculation of guanidine-dependent virus].
    LODDO B; FERRARI W; BROTZU G; SPANEDDA A
    Rass Med Sarda; 1963; 65():215-9. PubMed ID: 13931208
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of a guanidine-dependent strain of poliovirus 1 in sucrose density and pH gradients.
    La Colla P; Marcialis MA; Mereu GP; Loddo B
    Experientia; 1972 Sep; 28(9):1115-7. PubMed ID: 4353037
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Sabin live poliovirus vaccine in Japan. 3. Studies on the method of administration of Sabin vaccine for babies.
    Kono R
    Jpn J Med Sci Biol; 1967 Apr; 20(2):151-66. PubMed ID: 4293412
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiviral activity of guanidine and D-penicillamine. I. Inhibition by guanidine and D-penicillamine of RNA synthesis of poliovirus].
    Tagliamonte A; Mazzucato P; Scarpa B; Loddo B
    Boll Soc Ital Biol Sper; 1967 Jun; 43(11):643-4. PubMed ID: 4294522
    [No Abstract]   [Full Text] [Related]  

  • 20. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.